
Director, Genome Editing Off-Target R&D
MaxCyte, Inc, Waltham, MA, United States
A leading biotechnology company is seeking a Director of R&D to lead their SeQure portfolio. This role involves overseeing the development of advanced assays for genome editing, managing a multidisciplinary team, and driving strategic innovations. Candidates should have a Ph.D. and extensive experience in biotechnology, particularly in genome editing technologies and assay development. A competitive salary between $220,000 and $230,000 and comprehensive benefits are offered.
#J-18808-Ljbffr